Procurement Summary
Country : Brazil
Summary : Registration of Prices for the Eventual Acquisition of Oncology and Adjuvant Medications (Sunitinib, Nivolumab, Pembrolizumab, Etc.).
Deadline : 08 Apr 2024
Other Information
Notice Type : Tender
TOT Ref.No.: 98676917
Document Ref. No. : 728/2023
Financier : Self Financed
Purchaser Ownership : Public
Tender Value : Refer Document
Purchaser's Detail
Name :Login to see tender_details
Address : Login to see tender_details
Email : Login to see tender_details
Login to see detailsTender Details
Object: Electronic Auction - Price registration for the possible acquisition of oncological and adjuvant medications (sunitinib, nivolumab, pembrolizumab, etc.). 59 hours and from 2:00 pm to 5:59 pm
Proposal Delivery: from 12/019981d172c851bd4e8a1788d5726c2d33/2024 at 08:00
SUNITINIB, MALATE COMPOSITION, CONCENTRATION 50 MG
Quantity: 4416
IMATINIB MESYLATE, DOSAGE 100 MG
Quantity: 720
OSIMERTINIB, CONCENTRATION 80 MG
Quantity: 1440
NINTEDANIB, SALT ESYLATE COMPOSITION, CONCENTRATION 150 MG
Quantity: 28800
NIVOLUMAB, CONCENTRATION 10 MG/ML, 19981d172c851bd4e8a1788d5726c2d3PHARMACEUTICAL FORM INJECTABLE SOLUTION
Quantity: 936
NIVOLUMAB, CONCENTRATION 10 MG/ML, PHARMACEUTICAL FORM INJECTABLE SOLUTION
Quantity: 1512
OCRELIZUMAB, CONCENTRATION 30 MG/ML, PHARMACEUTICAL FORM SOLUTION FOR INFUSION
Quantity: 48
OLAPAR IBE, CONCENTRATION 150 MG
Quantity: 2880
PALBOCICLIBE, CO19981d172c851bd4e8a1788d5726c2d3NCENTRATION 125 MG
Quantity: 2016
PAZOPANIB, CONCENTRATION 400 MG
Quantity: 4320
PANITUMOMAB, CONCENTRATION 20 MG/ML, PHARMACEUTICAL FORM INJECTABLE SOLUTION
Quantity: 1440
PEMBROLIZUMAB, CONCENTRATION 25 MG/ML, PHARMACEUTICAL FORM EUTICA INJECTABLE SOLUTION
Quantity: 648
PERTUZUMAB, CONCENTRATION 3019981d172c851bd4e8a1788d5726c2d3MG/ML, PHARMACEUTICAL FORM INJECTABLE SOLUTION
Quantity: 120
PIRFENIDONE, CONCENTRATION 267 MG
Quantity: 25920
RIBOCICLIB, SUCCINATE COMPOSITION, CONCENTRATION 200 MG
Quantity: 966
RITUxIMAB, DOSAGE 10MG/ML, INDICATION INJECTABLE SOLUTION EL
Quantity: 472
RITUxIMAB, DOSAGE 10MG/ML, INDICATIONS ONLY19981d172c851bd4e8a1788d5726c2d3INJECTABLE SOLUTION
Quantity: 1248
RUxOLITINIB, CONCENTRATION 5 MG
Quantity: 1440
RUxOLITINIB, CONCENTRATION 20 MG
Quantity: 1440
SECUKINUMAB, CONCENTRATION 150 MG/ML, PHARMACEUTICAL FORM INJECTABLE SOLUTION
Quantity: 168
SO RAFENIB TOSYLATE, CONCENTRATION 200 MG
Quantity: 11520
TEMOZOLOMIDE19981d172c851bd4e8a1788d5726c2d3, CONCENTRATION 2...
Documents
Tender Notice